2026
Supports exceptional reintroduction of acetamiprid in 2026
In 2026, François Patriat defended a limited, exceptional reintroduction of acetamiprid to 'put an end to bans without replacements', amid a highly contested debate over this neonicotinoid.
- State of the evidence
- Documented
- Attribution
- Personally implicated
Sources · 1
- [1]
Last verified: 7 September 2026
